Literature DB >> 4914942

In-vitro interaction of Shigella flexneri with leukocytes and HeLa cells.

O Calabi.   

Abstract

Entities:  

Mesh:

Year:  1970        PMID: 4914942     DOI: 10.1093/infdis/122.1-2.1

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  7 in total

1.  [Past and present aspects of diarrheal disease in childhood. Clinical study and treatment (author's transl)].

Authors:  J P Guggenbichler; G B Stickler
Journal:  Infection       Date:  1975       Impact factor: 3.553

2.  Correlation between the susceptibility of E. coli to phagocytosis and their ability to invade HeLa cells in vitro.

Authors:  F Cian; B Bisiacchi; G D Rottini; P Patriarea
Journal:  Experientia       Date:  1977-08-15

3.  In vitro interaction of Neisseria gonorrhoeae type 1 and type 4 with tissue culture cells.

Authors:  B R Brodeur; W M Johnson; K G Johnson; B B Diena
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

4.  Suppression of the intracellular growth of Shigella flexneri in cell cultures by interferon preparations and polyinosinic-polycytidylic acid.

Authors:  L L Gober; A E Friedman-Kien; E A Havell; J Vilcek
Journal:  Infect Immun       Date:  1972-03       Impact factor: 3.441

5.  HeLa cell infection by Yersinia enterocolitica: evidence for lack of intracellular multiplication and development of a new procedure for quantitative expression of infectivity.

Authors:  J A Devenish; D A Schiemann
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

6.  Mutation in Shigella flexneri resulting in loss of ability to penetrate HeLa cells and loss of glycerol kinase activity.

Authors:  R Kim; L M Corwin
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

7.  Epimers of moxalactam: in vitro comparison of activity and stability.

Authors:  R Wise; P J Wills; K A Bedford
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.